CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, today announced
CN Bio signs strategic partnership with Primetech Corporation to establish distribution channel for OOC solutions in Japan
Agreement establishes direct distribution channel for customers in Japan, providing local support and expertise. Partnership solidifies CN Bio’s
Evaluating Caco-2 cell’s gold-standard status in absorption, permeability and bioavailability Studies: Are Their Limitations Justified?
In the realm of pharmaceutical research, Caco-2 cells have long been heralded as the gold standard for studying intestinal absorption and
Meet the CN Bio team – Oliver Culley
Welcome back to our “Meet the CN Bio team” blog series, where we are showcasing the unique expertise and talent that makes us who we are. We caught
CN Bio launches PhysioMimix Bioavailability assay kit: Human 18
Unique solution enabling researchers to profile human oral drug bioavailability in vitro, in their own laboratories Cambridge, UK, 14 November
User Group Meeting 2024 – Recap
Meet the CN Bio team – Uranbileg Myagmarsuren
Welcome back to our “Meet the CN Bio team” blog series, where we are showcasing the unique expertise and talent that makes us who we are. We sat
6 Challenges in ADME Drug Development
When developing drugs, we rely heavily on in vitro, in vivo animal and in silico models to predict how the human body will interact with drugs before
Meet the CN Bio team – Joanna Michalowska
Welcome to our new "Meet the CN Bio team" blog series, where you'll get a behind-the-scenes look at the incredible individuals who make our company